Overview

A Long-term, Extension Study of E2020 in Patients With Dementia With Lewy Bodies

Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety and efficacy of E2020 in patients with Dementia with Lewy Bodies (DLB).
Phase:
Phase 2
Details
Lead Sponsor:
Eisai Co., Ltd.
Treatments:
Donepezil